KUALA LUMPUR, Jan 31 (Bernama) -- KoverNow, an insurtech start-up company based in Singapore, has announced the appointment of National University of Singapore (NUS) Associate Professor of Marketing, Juin-Kuan Chong as non-executive director.
Chong, who is a behavioural scientist and data scientist by training, currently carries out research focusing on the challenges of nudging people to adopt useful technology.
Chong’s expertise is in using behavioural and economic principles and data analytics and AI tools. His work has included studies into how people search for the best deal, decide who and what to trust and how they make decisions in strategic situations.
His appointment at KoverNow, which has developed a unique mobile insurance app, is intended to help the company adopt mechanisms to gain a more in-depth understanding of today’s consumers and their buying patterns.
Chong’s experience working with public agencies and companies across multiple industries and locations, gives him a unique perspective which KoverNow is keen to tap into.
In a statement, KoverNow Chief Executive Officer, Stephan Kaiser said: “Professor Chong has a rich history of advising start-ups in the application of big data and artificial intelligence to their marketing strategies.
“His appointment as a director will help us to identify solutions to the key challenges we are coming up against as a disruptor in the digital insurance market. We are excited to have him on board.”
Prior to Chong’s current tenure at NUS, he was Assistant Professor of Decision Science and Marketing, and a Senior tutor in Decision Science at the university. He also spent two years as Associate Professor of Marketing at Sungkyunkwan University in Seoul, Korea.
He has held research appointments for the Center for Behavioral Economics and the Institute of Data Science at NUS and has published research and reports which have been featured in more than 60 news outlets globally.
-- BERNAMA
Tuesday 31 January 2023
KOVERNOW APPOINTS MARKETING, DATA SCIENCE EXPERT AS NON-EXECUTIVE DIRECTOR
J-LEC UNVEILS NHK TV PROGRAM "THE MASTERFULLY MARBLED WORLD OF JAPANESE WAGYU BEEF"
AsiaNet 99514
The Japan Livestock Products Export Promotion Council (J-LEC) is honored to announce the production and broadcast of a program titled "The Masterfully Marbled World of Japanese Wagyu Beef" on NHK WORLD-JAPAN on February 1. The NHK program being released introduces the profound world of Wagyu beef and its global appeal from the stage at the "Wagyu Olympics," one of Japan's largest food-related exhibitions.
Logo:
https://kyodonewsprwire.jp/prwfile/release/M107543/202301272460/_prw_PI1fl_kWUjZn21.png
Photo:
https://kyodonewsprwire.jp/prwfile/release/M107543/202301272460/_prw_PI2fl_853Fpwq3.jpg
Wagyu is globally renowned for its melt-in-your-mouth fat, fine marbling, tender texture, unique aroma and delicate, mellow flavor unique among cattle breeds. Developed through selective breeding and original Japanese methods, Wagyu is regarded as some of the best beef in the world.
In 2022, Kagoshima Prefecture hosted the 12th National Competitive Exhibition of Wagyu, also known as the Wagyu Olympics, the largest Wagyu beef competition in Japan, and 438 cattle qualified from 41 prefectures in Japan gathered for the breeding cattle division. This competition is held once every five years in different locations in Japan to determine which Wagyu production farm is leading the continued pursuit of the world's highest-quality beef.
Tracing the history of the Wagyu Olympics over the past half-century reveals a transformation of working cattle in rural areas that were selected to be genetically improved into beef of the highest quality, subsequently becoming one of Japan's major exports. In 2021, Japanese beef export value exceeded 50 billion yen (approximately 500 million USD according to the exchange rate at the time). The Japanese government has set a goal of tripling that value by 2025. Wagyu is expected to set a new standard for increasing exports of other Japanese products related to agriculture, forestry and fisheries, as well as Japanese food and culinary exports. Also, regarding modern trends in global health consciousness, Wagyu beef's fat content has become valued as a positive indication of "quality over quantity."
In Japan, each head of Wagyu cattle is individually traceable under a certified system, and its meat quality grading and pedigree are strictly controlled by a certification organization. The information can be easily accessed by scanning QR codes on Wagyu beef that are provided by J-LEC.
Japanese Wagyu beef, with its distinctive marbling, has become the standard for top-quality beef among high-end consumers in Asia, and is increasingly in demand in Europe and the United States.
Broadcast details
- Date: February 1, 2023
- Time: 2:30 - 3:00, 7:30 - 8:00, 13:30 - 14:00, 19:30 - 20:00 (UTC)
- URL:
https://biz.jibtv.com/programs/the_masterfully_marbled_world_of_japanese_wagyu_beef/
About Japan Livestock Products Export Promotion Council (J-LEC)
J-LEC is a Japanese organization consisting of multiple local municipal representatives and sharing information with the world about Japanese livestock farming and the meat and egg production industries.
Website: http://jlec-pr.jp/en/
Instagram: https://www.instagram.com/beef_japan_official/
Facebook: https://www.facebook.com/Beef-Japan-101603855192050/
Source: Japan Livestock Products Export Promotion Council
Thursday 26 January 2023
METADREAM LAUNCHES BONDEE, A NEXT-GEN SOCIAL APP
Metadream launches Bondee, a next-gen social app (Graphic: Business Wire)
SINGAPORE, Jan 26 (Bernama-BUSINESS WIRE) -- Metadream, a Singapore-based tech startup, recently launched Bondee, a next-gen social app, in Asia. Many have downloaded the app, drawn by its diverse and trendy avatars as well as its novel interactive features. Last week, Bondee ranked as the #1 free app in the App Store.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230125005382/en/
According to insiders, Metadream, an independent tech company based in Singapore, acquired the intellectual property rights of the app True.ly in May 2022. After that, Metadream made a creative and international transformation of this app and gradually launched Bondee around the world by the end of 2022. The company was founded by investors from the United States and Australia. In addition to Japan and South Korea as the product, R&D, and operational bases, there are three independent data centers in Singapore, Japan, and the United States set up to ensure the safe use of products and meet the data security requirements of regional markets. Metadream also plans to set up regional operation centers in Thailand, Philippines, and other countries to meet the immediate demands of local users. In addition to Bondee, the company is also developing a series of metaverse creative products.
Bondee redefines social interactions as we know them. With this disruption of the social media industry, we have much to look forward to.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20230125005382/en/
Contact
METADREAM TECH PTE. LTD.
Metadream Team
Email: marketing@bondee.net
Source : METADREAM TECH PTE. LTD.
Friday 20 January 2023
JUMIO, FIRST IDENTITY PROOFING VENDOR SURPASSES US$200 MLN IN BOOKINGS
KUALA LUMPUR, Jan 19 (Bernama) -- Jumio, the provider of automated, end-to-end identity proofing, risk assessment and eKYC (Know Your Customer) solutions, became the first identity company to clear well over US$200 million in bookings which saw the completion of both the largest new deal and the largest total deal in the fourth quarter of 2022. (US$1 = RM4.32)
Thursday 19 January 2023
CLOUDFLARE ANNOUNCES PHIL WINSLOW AS VP OF STRATEGIC FINANCE, TREASURY, AND INVESTOR RELATIONS
SAN FRANCISCO, Jan 18 (Bernama-BUSINESS WIRE) -- Cloudflare, Inc. (NYSE: NET), the security, performance, and reliability company helping to build a better Internet, today announced the appointment of Phil Winslow as Vice President of Strategic Finance, Treasury, and Investor Relations. Winslow previously covered Cloudflare as a financial analyst at Credit Suisse, where he was the global head of the software team, and at Wells Fargo.
“Phil has extensive expertise in the software industry, and we have developed a relationship with him prior to this search, as he has covered Cloudflare for years,” said Matthew Prince, CEO and co-founder, Cloudflare. “As someone who has been following our growth even before our IPO, welcoming him to Cloudflare is a huge testament to our rapid growth, innovation, and ability to deliver strong execution and profitability at scale.”Winslow will be responsible for ensuring the company’s long-term financial strategy is optimized for growth and profitability, managing its capital structure and treasury processes to support strategic goals and operational objectives, and overseeing investor relations. These functions are particularly important as Cloudflare continues to experience rapid growth, scales free cash flow generation, and becomes an increasingly important player in the market for cloud-based Zero Trust, network, and application services, and developer platforms. Reporting to Cloudflare’s Chief Financial Officer, Thomas Seifert, Winslow will work closely with the leadership team to develop and implement strategies that support Cloudflare’s long-term success.
“Phil has a proven track record and brings a wealth of knowledge and expertise to his role at Cloudflare. As an influential software analyst, he has worked alongside institutional investors to develop investment strategies for software companies, as well as with issuers to execute successful capital markets transactions,” said Thomas Seifert, Chief Financial Officer at Cloudflare. “We’re thrilled to have Phil on board as we continue towards our goal of $5 billion in annualized revenue in the next five years.”
Monday 16 January 2023
FREEDOMPAY TO UNLEASH THE POWER OF PAY AT NRF 2023
NEW YORK, National Retail Federation, Jan 16 (Bernama-GLOBE NEWSWIRE) -- FreedomPay, the global leader in Next Level Commerce™ and the commerce technology platform of choice for global retail, hospitality and payments brands including Marriott, Foot Locker, Shake Shack, Engage People, and Castles Technology, will showcase its innovations and partnership announcements this week at NRF in booth #4250.
The event will mark the launch of FreedomPay’s new call to action, Unleash the Power of Pay. As the commerce landscape evolves with new technologies and changing consumer needs, Unleash the Power of Pay introduces the notion of unleashing the power of payments to drive greater customer loyalty, leverage business intelligence insights, and bring value-added services.
“FreedomPay is excited to make a splash at this year’s NRF and to launch Unleash the Power of Pay. The concept is a testament to our award-winning technology and best-in-class partner network that is enabling billions of transactions in more than 75 countries across the globe,” said Tom Durovsik, Founder & CEO of FreedomPay.
As part of its line-up at NRF, FreedomPay will host a roundtable discussion on Monday, January 16 at 10:30AM at booth #4250 with industry influencers Castles Technology, Charter Communications, and Elo Touch, moderated by Dale Laszig of the Green Sheet. The event, Next Level Commerce™: Unleashing the Power of Pay, will focus on the challenges and opportunities across retail, the trends influencing retail's future, and strategies for merchants to navigate the changing retail sector. Those who would like to attend virtually are encouraged to register here.
FreedomPay also announces the publication of a new industry white paper The Next Level of Global Payments: Unleash the Power of Pay. The report highlights pivotal opportunities for retailers to elevate customer relationships and increase profit margins internationally, outlining strategies for security, safety, speed, simplicity, and customer satisfaction with service across borders. Download now to read the bespoke report.
FreedomPay’s global footprint continues to grow through the power of its partner network and new integrations to allow merchants to Unleash the Power of Pay for their customers. FreedomPay also announced in the days leading up to NRF 2023 new partnerships that will bring its solutions to more merchants around the world.
Moneris Solutions Corporation (“Moneris”), the largest payment processor in Canada*, will now be able to offer its merchants access to FreedomPay’s commerce technology platform, bringing an enhanced checkout experience to millions of shoppers across Canada.
FreedomPay also announced an integration with Flooid, bringing enhanced innovation, choice, and flexibility to retailers around the globe on the Flooid platform.
To learn more about FreedomPay, visit us at NRF booth #4250 or www.freedompay.com.
About FreedomPay
FreedomPay’s Next Level Commerce™ platform transforms existing payment systems and processes from legacy to leading edge. As the premier choice for many of the largest companies across the globe in retail, hospitality, lodging, gaming, sports and entertainment, foodservice, education, healthcare and financial services, FreedomPay's technology has been purposely built to deliver rock solid performance in the highly complex environment of global commerce. The company maintains a world-class security environment and was first to earn the coveted validation by the PCI Security Standards Council against Point-to-Point Encryption (P2PE/EMV) standard in North America. FreedomPay's robust solutions across payments, security, identity, and data analytics are available in-store, online and on-mobile and are supported by rapid API adoption. The award winning FreedomPay Commerce Platform operates on a single, unified technology stack across multiple continents allowing enterprises to deliver an innovative Next Level experience on a global scale. www.freedompay.com
*Based on total number of transactions processed in Canada
Jennifer Tayebi
Hill+Knowlton Strategies for FreedomPay
+1 734 395 0780
Jennifer.Tayebi@hkstrategies.com
SOURCE : FreedomPay
Friday 13 January 2023
HYATT REGENCY SERAGAKI ISLAND OKINAWA OFFERS ECOTOURISM ACTIVITY
KUALA LUMPUR, Jan 13 (Bernama) -- Hyatt Regency Seragaki Island Okinawa, located on Seragaki Island in Onna Village on the west coast of Okinawa, is offering an ecotourism activity, “Learn About the Sea of Seragaki Island and Clownfish” to support the conservation and restoration of clownfish around the island.
Reservation for the activity is now available via "FIND”, an experiences platform launched in November last year through Hyatt's industry-leading World of Hyatt loyalty programme designed to complement members' wellbeing journeys and meet them where they are.
As part of the "Seragaki Island Clownfish Restoration Project" which began in June 2021, the activity offers guests a snorkeling or diving experience around the clownfish-nurturing project zone along with a lecture on SDG 14 titled "Life Below Water: conserve and sustainably use the oceans, seas and marine resources for sustainable development”.
“Through this programme, the hotel aims to help participants deepen their understanding of environmental conservation and establish a sustainable tourism system by giving part of the programme proceeds back to the future of nurturing the clownfish,” it said in a statement.
The 75-minute "Learn About the Sea of Seragaki Island and Clownfish" activity starts with a lecture on the background of clownfish conservation and breeding, and their natural habitats.
After deepening understanding of environmental issues surrounding marine life, participants will explore firsthand the clownfish nursery area around Seragaki Island by snorkeling or diving.
The Seragaki Island Clownfish Restoration Project, driven by Hyatt Regency Seragaki Island Okinawa is a collaboration with the Marine Climate Change Unit at Okinawa Institute of Science and Technology Graduate University.
-- BERNAMA
SABIN VACCINE INSTITUTE RECEIVES $35 MILLION FROM BARDA WITH POTENTIAL OF UP TO $214 MILLION FOR EBOLA SUDAN AND MARBURG VACCINES
WASHINGTON, Jan 13 (Bernama-GLOBE NEWSWIRE) -- The Sabin Vaccine Institute today announced that the Biomedical Advanced Research and Development Authority (BARDA) has awarded Sabin a multi-year contract with funding potential for up to $214 million to advance the development and production of single-dose vaccine candidates for Ebola Sudan and Marburg virus diseases.
There are currently no licensed vaccines against Ebola Sudan and Marburg viruses, which cause hemorrhagic fever and kill approximately half the people infected.BARDA, part of the U.S. Department of Health and Human Services’ Administration for Strategic Preparedness and Response (ASPR), will initially invest approximately $35 million to produce up to 100,000 doses of Sabin’s Ebola Sudan virus (ChAd3-SUDV) vaccine. These vaccines may be used as part of ongoing U.S. preparedness efforts and in response to future global outbreaks.
Wednesday 11 January 2023
EXEO GLOBAL COMPLETES ACQUISITION OF TELISTAR SOLUTIONS
KUALA LUMPUR, Jan 11 (Bernama) -- EXEO Global Pte Ltd (EXEO Global), the regional headquarters of Tokyo Stock Exchange-listed EXEO Group Inc has completed the acquisition of Telistar Solutions Pte Ltd (Telistar), an information technology (IT) service solutions provider.
The acquisition allows EXEO Global to grow its capabilities in managed IT services, via an established solutions provider trusted by government organisations, educational and financial institutions, healthcare providers and large retail brand owners, it said in a statement.
“Following the amalgamation exercise with its subsidiary, ARCO Pte Ltd and acquisition of Telistar, EXEO Global is now set to become a major player in the space of Managed IT Services within Asia Pacific and beyond,” it said.
The company is currently focused on expanding its services and product offerings to the market, to provide greater value to its clients, utilising technology to allow them to enjoy quality Managed IT Services at greater cost efficiencies.
“Telistar is well-known in the space of Managed IT Services in Singapore, and their team possesses strong technical knowledge and solid work ethics which are highly valued by their clients and partners.
“We believe that we are able to work closely together to develop innovative solutions for the market that will create greater value for all our stakeholders, clients and potential customers,” said EXEO Global chief executive officer, Imaizumi Fumitoshi.
Meanwhile, Telistar Solutions managing director, Steven Phua says Telistar has come a long way since it started the business in 2007, and is now ready for its next phase of growth.
“We believe that EXEO Global is the right partner to help the business evolve and grow into a global player in the space of Managed IT Services, and we look forward to being part of this strong, creative team,” he said.
-- BERNAMA
Tuesday 10 January 2023
CONAGEN BEGINS COMMERCIAL PRODUCTION OF TYRIAN PURPLE FOR TEXTILE DYE
KUALA LUMPUR, Jan 10 (Bernama) -- Conagen has commenced the successful scale-up of its sustainable, cost-effective Tyrian purple, a historically coveted and expensive dye found in rare and limited sources in marine nature.
Conagen in a statement said it was the world's first and only biotechnology company commercialising a sustainable Tyrian purple by fermentation.
“As with any biologically-sourced textile dye, this colour-fast compound reduces pollution and carbon footprints when used as an alternative to petrochemically synthesised dyes commonly used in the textiles industry,” it said.
Conagen’s Tyrian purple, produced by precision fermentation and bioconversion, is a natural, sustainable dye ideal for textile companies under pressure to deliver fashions more sustainably and with a reduced global environmental footprint, especially from manufacturing.
“By leveraging Conagen’s bioengineering and commercial manufacturing capabilities, we’re unlocking Tyrian purple’s great potential as an accessible and sustainable dye.
“We expect Tyrian purple to inspire fresh ideas in multiple industries, making this rare and exciting colour more marketable with planet-conscious consumers,” said its senior vice president of innovation, Casey Lippmeier, PhD.
The Tyrian purple technology is based on two of Conagen’s many key bioengineering platforms, which enable accelerated product development timelines for its competitive phenolics, terpenoids, proteins and peptide molecules
The company aims to replace petroleum-based ingredients and reduce carbon footprints with green technologies. Tyrian purple adds to Conagen’s natural colour offerings, including several carotenoids made by fermentation which have been scaled to global production.
-- BERNAMA
GETGO PICKS JUMIO AS KEY TO UNLOCK FASTER DIGITAL ONBOARDING FOR NEW DRIVERS
Friday 6 January 2023
DUCK CREEK TO ACQUIRE IMBURSE PAYMENTS, A MODERN PAYMENTS PLATFORM
Boston, MA, Jan 6 (Bernama-GLOBE NEWSWIRE) -- Duck Creek Technologies (NASDAQ: DCT) (“Duck Creek”), the intelligent solutions provider defining the future of property and casualty (P&C) insurance, today announced a definitive agreement to acquire Imburse Payments (“Imburse”), a Swiss-based modern payments platform.
Imburse’s cloud-native software-as-a-service (SaaS) payment solution is built for the insurance industry. The modern payments platform brings greater ease and efficiency into end-to-end insurance transactions. Imburse enables insurance carriers to quickly connect to the entire payments ecosystem at a lower cost, seamlessly integrate with existing finance infrastructure and processes, and manage multiple partners for collections and disbursements, all in one place. The platform is consumer friendly and provides policyholders with both an easy-to-use, flexible payments experience and the ability to quickly and securely direct payments.
As part of Duck Creek, Imburse will continue to serve its existing client base and markets, while accelerating expansion plans for new clients across Europe and into North America and Asia-Pacific. The Imburse platform will continue to be available on a stand-alone basis and will also be fully integrated with Duck Creek’s suite of technology solutions, further enabling carriers’ digital transformation goals with modern tools.
“Imburse has developed a great product for the global insurance industry that is not only easy to integrate and implement, but also gives carriers incredible flexibility and payment choices,” said Mike Jackowski, CEO of Duck Creek Technologies. “Imburse has a strong team that embodies Duck Creek’s core values. They have deep expertise across the payments ecosystem and will help to broaden Duck Creek’s insurance industry leadership.”
“Being part of Duck Creek will further accelerate our mission to simplify how businesses around the world access the global payments ecosystem,” said Oliver Werneyer, CEO of Imburse. “We are excited to be part of Duck Creek and to work jointly to deliver modern technology innovations that transform the insurance industry for the future.”
The acquisition remains subject to customary closing conditions and is expected to close during the second fiscal quarter of 2023.
Conference Call Information
Duck Creek Technologies will host a conference call today, January 5, 2023, at 5:00 p.m. (Eastern Time) to discuss Duck Creek’s financial results and business outlook, as well as the proposed acquisition of Imburse Payments. A live webcast of the call will be available on the “Investor Relations” page of the Duck Creek’s website at https://ir.duckcreek.com/. To access the call by phone, please go to this link (registration link), and you will be provided with dial in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. A replay of the webcast will also be available for a limited time at https://ir.duckcreek.com/.
About Imburse Payments
Imburse is a modern payments platform built for insurers. Via a single connection, directly or through a current core system provider, insurance carriers can access the entire global payment ecosystem to collect or pay-out using any technology, any provider, in any market.
About Duck Creek Technologies
Duck Creek Technologies (NASDAQ: DCT) is the intelligent solutions provider defining the future of the property and casualty (P&C) and general insurance industry. We are the platform upon which modern insurance systems are built, enabling the industry to capitalize on the power of the cloud to run agile, intelligent, and evergreen operations. Authenticity, purpose, and transparency are core to Duck Creek, and we believe insurance should be there for individuals and businesses when, where, and how they need it most. Our market-leading solutions are available on a standalone basis or as a full suite, and all are available via Duck Creek OnDemand. Visit www.duckcreek.com to learn more. Follow Duck Creek on our social channels for the latest information – LinkedIn and Twitter.
Attachment
Drake Manning
Duck Creek Technologies
drake.manning@duckcreek.com
Carley Bunch Duck
Creek Technologies
carley.bunch@duckcreek.com
Michael Sharp
Imburse Payments
michael.sharp@imbursepayments.com
SOURCE : Duck Creek Technologies
Wednesday 4 January 2023
TESSA THERAPEUTICS PROVIDES STRATEGIC OUTLOOK AND CORPORATE UPDATE FOR 2023
Tessa to prioritize allogeneic CAR-T cell therapy platform following strong safety and efficacy data presented during ASH 2022 SINGAPORE, Jan 4 (Bernama-GLOBE NEWSWIRE) -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, announced today that the company will prioritize development of its allogeneic “off-the-shelf” CD30.CAR-modified Epstein-Barr virus-specific T-cell (EBVST) therapy platform, while seeking strategic options for the development of its TT11 autologous CAR-T platform with other companies. The decision to prioritize the allogeneic or “off-the-shelf-approach” over the autologous platform followed progress and new data with its TT11X clinical program, including strong safety and efficacy data presented in an oral podium presentation at the 64th Annual Meeting of the American Society of Hematology (ASH). The data demonstrated TT11X to be well-tolerated at all dosing levels, eliciting a 79% overall response rate and 43% complete response rate among 14 heavily pre-treated CD30-positve Hodgkin lymphoma patients. These developments are the first of what is expected to be a milestone-rich year ahead for Tessa as the company seeks to build the value of its pipeline to its fullest potential with available resources. “I believe that this strategic refocus on our allogeneic platform positions the company at the forefront of CAR-T innovation during 2023 and beyond,” stated Thomas Willemsen, President and CEO of Tessa Therapeutics. “This optimism is based on the compelling safety and efficacy data that continue to be generated by our TT11X program and the potential patient benefit in treating CD30-positive lymphomas, and potentially solid tumors where there is significant unmet medical need.” “Our scientific efforts are directed toward enhancing cell performance and durability of our allogeneic EBVST cells - a key challenge faced by current allogeneic approaches, and hence a key differentiating factor in our platform approach.” stated Ivan Horak, M.D., Chief Medical Officer and Chief Scientific Officer of Tessa Therapeutics. Tessa Corporate Update During 2022, Tessa enhanced its executive management team with the appointment of Thomas Willemsen as President and CEO and Wilson W. Cheung as CFO. The company also expanded its board with the addition of Amy Schulman and Darren Carroll from Polaris Partners, which led the company’s US$126M Series A round. Today, Tessa has announced that Steve Krognes will serve as the company’s new Chairman of the Board of Directors. Mr. Krognes, who was previously a director on Tessa’s Board, replaces Dr. Göran Ando as Chairman after nearly three years. “We are very pleased to welcome Steve Krognes to Chairman of the Board. Steve brings a deep background in business development and partnering and will work closely with management as we embark on this important period in the company’s evolution,” stated Mr. Willemsen. “We would like to extend our deepest gratitude to Dr. Ando for his leadership and contribution to the growth and development of Tessa. He has been instrumental in our company’s success and his influence will be felt at Tessa for years to come.” Tessa Therapeutics at “JPM Week 2023” The Tessa executive team will be in San Francisco during “JPM Week 2023” and available for one-on-one meetings with accredited investors, as well as biotech and pharmaceutical companies to discuss partnering opportunities and to execute its plan for the manufacturing facility divestiture. For those interested in scheduling meetings, please contact Jonathan Nugent (jnugent@tiberend.com) and Daniel Kontoh-Boateng (dboateng@tiberend.com). About Tessa Therapeutics Singapore-based Tessa Therapeutics is a clinical-stage biotechnology company developing next-generation cell therapies for the treatment of hematological cancers and solid tumors. Tessa’s CAR-T portfolio is highlighted by a proprietary allogeneic “off-the-shelf” cell therapy platform targeting a broad range of cancers in which Epstein Barr Virus Specific T Cells (EBVSTs) are augmented with CD30-CAR. A therapy using this platform, TT11X, is currently the subject of a Phase 1 clinical trial in CD30-positive lymphomas. Tessa’s pipeline also includes TT11, an autologous CD30-CAR-T therapy being investigated as a potential treatment for relapsed or refractory classical Hodgkin lymphoma as both a monotherapy (Phase 2) and combination therapy (Phase 1b). For more information on Tessa, visit www.tessacell.com. Cautionary Note on Forward Looking Statements This press release contains forward-looking statements (within the meaning of the Private Securities Litigation Reform Act of 1995, to the fullest extent applicable) including, without limitation, with respect to various regulatory filings or clinical study developments of the Company. You can identify these statements by the fact that they use words such as “anticipate,” “estimate”, “expect”, “project”, “intend”, “plan”, “believe”, “target”, “may”, “assume” or similar expressions. Any forward-looking statements in this press release are based on management’s current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release, including, without limitation, those related to the Company’s financial results, the ability to raise capital, dependence on strategic partnerships and licensees, the applicability of patents and proprietary technology, the timing for completion of the clinical trials of its product candidates, whether and when, if at all, the Company’s product candidates will receive marketing approval, and competition from other biopharmaceutical companies. The Company cautions you not to place undue reliance on any forward-looking statements, which speak only as of the date they are made, and disclaims any obligation to publicly update or revise any such statements to reflect any change in expectations or in events, conditions or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements. Any forward-looking statements contained in this press release represent the Company’s views only as of the date hereof and should not be relied upon as representing its views as of any subsequent date. The Company’s products are expressly for investigational use pursuant to a relevant investigational device exemption granted by the U.S. Food & Drug Administration, or equivalent competent body. Tessa Therapeutics Investor Contact Wilson W. Cheung Chief Financial Officer wcheung@tessacell.com Tessa Therapeutics Media Contact Tiberend Strategic Advisors, Inc. Bill Borden +1-732-910-1620 bborden@tiberend.com Dave Schemelia +1-609-468-9325 dschemelia@tiberend.com SOURCE : Tessa Therapeutics Ltd |
Sunday 1 January 2023
Executive aviation industry going through biggest transition: Jetex
KUALA LUMPUR, Dec 30 (Bernama) -- The executive aviation industry is going through its biggest-ever transition with businesses and ultra-high-net-worth (UHNW) travellers developing a greater awareness of the huge time and convenience benefits it offers, said executive aviation services provider, Jetex.
Its founder and chief executive officer Adel Mardini said the industry has shown its ability to adapt and remain connected to its customers, spurring their desire to travel and discover within an environment of luxury and supreme service.
In the company’s 2022 annual review, Mardini said data from aviation data research firm, Wingx, revealed that 2021 saw 3.3 million private flights globally, the most on record, and the industry is set to grow by 10 per cent in the post-pandemic period.
“A much larger number of ultra-premium passengers continue to fly private rather than returning to first or business class. There has also been an increase in first-time private flyers for both business and family travel.
“As a result, sales demand for both new and pre-owned jets has climbed to record levels and is expected to continue, with 8,400-8,500 new business jet deliveries between 2022 and 2031 at an estimated value of US$264-US$274 billion (US$1=RM4.415),” he said.
Mardini said demand for private air travel is expected to grow further year-on-year (y-o-y), and Jetex is thrilled to be part of the growth.
“With more flexibility, time efficiency, and a larger possible reach, the demand for private air travel is expected to grow further y-o-y and Jetex is thrilled to be part of this ongoing success story,” he said.
Jetex is recognised for delivering flexible, best-in-class trip support solutions to customers worldwide, and its services include private terminals, aircraft fueling, ground handling and global trip planning.
The Jetex 2002 review on the executive aviation industry can be accessed here.
-- BERNAMA